Relationship between leukemogenicity and in vivo inducibility of normal differentiation in mouse myeloid leukemia cells
- PMID: 278861
Relationship between leukemogenicity and in vivo inducibility of normal differentiation in mouse myeloid leukemia cells
Abstract
Leukemogenicity was studied in sensitive mouse myeloid leukemia cells that could be induced to undergo cell differentiation in vitro into mature granulocytes and macrophages by incubation with the inducer (certain proteins or glucocorticoids) and in resistant myeloid leukemia cells that could not be induced to differentiate into mature cells. Three sensitive and five resistant clones were tested. The resistant cells were much more leukemogenic than the sensitive cells, and the survival time of syngeneic mice inoculated with the sensitive cells. In a diffusion chamber in a syngeneic, inbred SL mouse without any additional manipulation or injection of inducer, the resistant cells remained undifferentiated, but the sensitive cells were induced to differentiate into mature granulocytes and macrophages and their proliferation rate decreased. These results suggested that the greater leukemogenicity of resistant cells is associated with some defect in inducibility of cell differentiation.
Similar articles
-
Prolongation of survival time of mice inoculated with myeloid leukemia cells by inducers of normal differentiation.Cancer Res. 1979 Aug;39(8):3167-71. Cancer Res. 1979. PMID: 287553
-
Survival of mice inoculated with non-differentiating myeloid leukemia cells is prolonged by the injection of an inducer of cell differentiation with a sensitizer.Gan. 1980 Aug;71(4):543-7. Gan. 1980. PMID: 6933130
-
Inhibition of differentiation of cultured mouse myeloid leukemia cells by nonsteroidal antiinflammatory agents and counteraction of the inhibition by prostaglandin E1.Cancer Res. 1979 Jun;39(6 Pt 1):2190-4. Cancer Res. 1979. PMID: 445417
-
Factors inhibiting differentiation of myeloid leukemia cells.Crit Rev Oncog. 1992;3(3):293-319. Crit Rev Oncog. 1992. PMID: 1616959 Review.
-
[Experimental model for differentiation therapy of leukemia].Gan To Kagaku Ryoho. 1993 Jun;20(8):1009-15. Gan To Kagaku Ryoho. 1993. PMID: 8099785 Review. Japanese.
Cited by
-
An anti-cancer derivative of butyric acid (pivalyloxmethyl buterate) and daunorubicin cooperatively prolong survival of mice inoculated with monocytic leukaemia cells.Br J Cancer. 1997;75(6):850-4. doi: 10.1038/bjc.1997.151. Br J Cancer. 1997. PMID: 9062406 Free PMC article.
-
1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.Proc Natl Acad Sci U S A. 1983 Jan;80(1):201-4. doi: 10.1073/pnas.80.1.201. Proc Natl Acad Sci U S A. 1983. PMID: 6296868 Free PMC article.
-
Patterns of maturation in short-term culture of human acute myeloid leukaemic cells.Br J Cancer. 1979 Nov;40(5):719-30. doi: 10.1038/bjc.1979.252. Br J Cancer. 1979. PMID: 292451 Free PMC article.
-
Antileukemic effect of alkyl phospholipids. II. Prolongation of survival times of leukemic mice by alkyl ethyleneglycophospholipids.Cancer Chemother Pharmacol. 1983;11(2):77-9. doi: 10.1007/BF00254249. Cancer Chemother Pharmacol. 1983. PMID: 6578883